United Therapeutics (UTHR) Tops Q4 EPS Views
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $544.33 +1.12%
Revenue Growth %: +1.5%
Financial Fact:
Total operating expenses: 169.6M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Revenue Growth %: +1.5%
Financial Fact:
Total operating expenses: 169.6M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q4 adjusted EPS of $3.21, $1.18 better than the analyst estimate of $2.03. Revenue for the quarter came in at $346.4 million versus the consensus estimate of $336.22 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Stifel Canada Starts BlackBerry (BB) at Buy
- KeyBanc Upgrades Nucor (NUE) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
